Alternative methods have been used to estimate appropriate treatment of malaria by restricting ACT coverage indicators to those children who had a positive Plasmodium falciparum histidine-rich protein 2 (HRP2) RDT result during the survey [5], since HRP2 antigen persists for several weeks after clearance of the infection [22, 23]. The gene discussed is HDGFL2; the disease is malaria.